Skip to content
PubMed This is a summary of 61 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 61 referenced papers

Top Authors

Zubair Baloch
University of Pennsylvania
Nicole A. Cipriani
University of Chicago
Rebecca S. Sippel
University of Wisconsin–Madison
Justine A. Barletta
Brigham and Women's Hospital
Akira Miyauchi
Kuma Hospital
Chan Kwon Jung
Catholic University of Korea
Yasuhiro Ito
Kuma Hospital
Ralf Paschke
University of Calgary
Tae Yong Kim
Ulsan College
Markus Eszlinger
University of Calgary

Top Institutions

Ranked by publications Top 10 institutions
07

Memorial Sloan Kettering Cancer Center

New York, United States

65 papers

References

References (61)
  1. 1

    Alternative schedules of levothyroxine administration.

    Geer M, Potter DM, Ulrich H

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2015; (72(5)):373-7 doi:10.2146/ajhp140250.

    PMID: 25694412
  2. 2

    Decisional conflict in patients considering diagnostic thyroidectomy with indeterminate fine needle aspirate cytopathology.

    Taylor BA, Hart RD, Rigby MH, et al.

    Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale 2016; (45()):16 doi:10.1186/s40463-016-0130-x.

    PMID: 26921257
  3. 3

    Surgical treatment of thyroid follicular neoplasms: results of a retrospective analysis of a large clinical series.

    Conzo G, Avenia N, Ansaldo GL, et al.

    Endocrine 2017; (55(2)):530-538 doi:10.1007/s12020-016-0953-2.

    PMID: 27075721
  4. 4

    Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular carcinoma.

    Jung SH, Kim MS, Jung CK, et al.

    Oncotarget 2016; (7(43)):69638-69648 doi:10.18632/oncotarget.11922.

    PMID: 27626165
  5. 5

    Clinical Features of Early and Late Postoperative Hypothyroidism After Lobectomy.

    Park S, Jeon MJ, Song E, et al.

    The Journal of clinical endocrinology and metabolism 2017; (102(4)):1317-1324 doi:10.1210/jc.2016-3597.

    PMID: 28324106
  6. 6

    Molecular profiling of thyroid nodule fine-needle aspiration cytology.

    Eszlinger M, Lau L, Ghaznavi S, et al.

    Nature reviews. Endocrinology 2017; (13(7)):415-424 doi:10.1038/nrendo.2017.24.

    PMID: 28361927
  7. 7

    Multiinstitutional Analysis of Thyroid Nodule Risk Stratification Using the American College of Radiology Thyroid Imaging Reporting and Data System.

    Middleton WD, Teefey SA, Reading CC, et al.

    AJR. American journal of roentgenology 2017; (208(6)):1331-1341 doi:10.2214/AJR.16.17613.

    PMID: 28402167
  8. 8

    Metastatic Follicular Thyroid Carcinoma and the Primary Thyroid Gross Examination: Institutional Review of Cases from 1990 to 2015.

    Glomski K, Nosé V, Faquin WC, Sadow PM

    Endocrine pathology 2017; (28(2)):177-185 doi:10.1007/s12022-017-9483-6.

    PMID: 28444500
  9. 9

    [Hypothyreosis after Hemithyroidectomy - surprisingly frequent complication in aftercare].

    Elmas F, Lauber F, Linder T, Müller W

    Laryngo- rhino- otologie 2018; (97(1)):24-29 doi:10.1055/s-0043-110856.

    PMID: 28597456
  10. 10

    The Molecular Landscape of Noninvasive Follicular Thyroid Neoplasm With Papillary-like Nuclear Features (NIFTP): A Literature Review.

    Basolo F, Macerola E, Ugolini C, et al.

    Advances in anatomic pathology 2017; (24(5)):252-258 doi:10.1097/PAP.0000000000000163.

    PMID: 28777140
  11. 11

    Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category IV (FN/SFN).

    Kuru B, Kefeli M

    Diagnostic cytopathology 2018; (46(6)):489-494 doi:10.1002/dc.23923.

    PMID: 29524316
  12. 12

    Concurrent Milk Ingestion Decreases Absorption of Levothyroxine.

    Chon DA, Reisman T, Weinreb JE, et al.

    Thyroid : official journal of the American Thyroid Association 2018; (28(4)):454-457 doi:10.1089/thy.2017.0428.

    PMID: 29589994
  13. 13

    Impact of historic histopathologic sample review on the risk of recurrence in patients with differentiated thyroid cancer.

    Pitoia F, Jerkovich F, Urciuoli C, et al.

    Archives of endocrinology and metabolism 2018; (62(2)):157-163 doi:10.20945/2359-3997000000020.

    PMID: 29641733
  14. 14

    A Proposal for Separation of Nuclear Atypia and Architectural Atypia in Bethesda Category III (AUS/FLUS) Based on Differing Rates of Thyroid Malignancy.

    Johnson DN, Cavallo AB, Uraizee I, et al.

    American journal of clinical pathology 2019; (151(1)):86-94 doi:10.1093/ajcp/aqy109.

    PMID: 30212867
  15. 15

    Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.

    Steward DL, Carty SE, Sippel RS, et al.

    JAMA oncology 2019; (5(2)):204-212 doi:10.1001/jamaoncol.2018.4616.

    PMID: 30419129
  16. 16

    Thyroid tumors with follicular architecture.

    Turk AT, Wenig BM

    Annals of diagnostic pathology 2019; (38()):51-58 doi:10.1016/j.anndiagpath.2018.10.007.

    PMID: 30419427
  17. 17

    NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.

    Haddad RI, Nasr C, Bischoff L, et al.

    Journal of the National Comprehensive Cancer Network : JNCCN 2018; (16(12)):1429-1440 doi:10.6004/jnccn.2018.0089.

    PMID: 30545990
  18. 18

    Modified Transverse-Vertical Gross Examination: a Better Method for the Detection of Definite Capsular Invasion in Encapsulated Follicular-Patterned Thyroid Neoplasms.

    Oh HS, Kim SJ, Song E, et al.

    Endocrine pathology 2019; (30(2)):106-112 doi:10.1007/s12022-019-9565-8.

    PMID: 30661168
  19. 19

    Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): a review for clinicians.

    Rosario PW, Mourão GF

    Endocrine-related cancer 2019; (26(5)):R259-R266.

    PMID: 30913533
  20. 20

    An Evaluation of CD61 Immunohistochemistry in Identification of Vascular Invasion in Follicular Thyroid Neoplasms.

    Cracolici V, Parilla M, Henriksen KJ, Cipriani NA

    Head and neck pathology 2020; (14(2)):399-405 doi:10.1007/s12105-019-01048-8.

    PMID: 31218593
  21. 21

    FACTORS INFLUENCING THE SUCCESSFUL MAINTENANCE OF EUTHYROIDISM AFTER LOBECTOMY IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA: A SINGLE-CENTER STUDY.

    Ha TK, Kim DW, Park HK, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2019; (25(10)):1035-1040 doi:10.4158/EP-2019-0153.

    PMID: 31241363
  22. 22

    The surgical dilemma of primary surgery for follicular thyroid neoplasms.

    Staubitz JI, Musholt PB, Musholt TJ

    Best practice & research. Clinical endocrinology & metabolism 2019; (33(4)):101292 doi:10.1016/j.beem.2019.101292.

    PMID: 31434622
  23. 23

    Role of frozen section in the surgical management of indeterminate thyroid nodules.

    Najah H, Tresallet C

    Gland surgery 2019; (8(Suppl 2)):S112-S117 doi:10.21037/gs.2019.04.07.

    PMID: 31475098
  24. 24

    Follicular Thyroid Neoplasms: Comparison of Clinicopathologic and Molecular Features of Atypical Adenomas and Follicular Thyroid Carcinomas.

    Cracolici V, Ritterhouse LL, Segal JP, et al.

    The American journal of surgical pathology 2020; (44(7)):881-892 doi:10.1097/PAS.0000000000001489.

    PMID: 32282345
  25. 25

    Volume, outcomes, and quality standards in thyroid surgery: an evidence-based analysis-European Society of Endocrine Surgeons (ESES) positional statement.

    Lorenz K, Raffaeli M, Barczyński M, et al.

    Langenbeck's archives of surgery 2020; (405(4)):401-425 doi:10.1007/s00423-020-01907-x.

    PMID: 32524467
  26. 26

    Prevalence of and risk factors for hypothyroidism after hemithyroidectomy: a systematic review and meta-analysis.

    Li Z, Qiu Y, Fei Y, et al.

    Endocrine 2020; (70(2)):243-255 doi:10.1007/s12020-020-02410-5.

    PMID: 32638212
  27. 27

    Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up.

    Kim SY, Kim HJ, Kim SM, et al.

    Frontiers in endocrinology 2020; (11()):520 doi:10.3389/fendo.2020.00520.

    PMID: 32849303
  28. 28

    Patients' Reaction to Diagnosis with Thyroid Cancer or an Indeterminate Thyroid Nodule.

    Pitt SC, Saucke MC, Wendt EM, et al.

    Thyroid : official journal of the American Thyroid Association 2021; (31(4)):580-588 doi:10.1089/thy.2020.0233.

    PMID: 33012267
  29. 29

    ThyroSeq v3 for Bethesda III and IV: An institutional experience.

    Desai D, Lepe M, Baloch ZW, Mandel SJ

    Cancer cytopathology 2021; (129(2)):164-170 doi:10.1002/cncy.22362.

    PMID: 33030808
  30. 30

    Current surgical treatment of intermediate risk differentiated thyroid cancer: a systematic review.

    Guo MY, Wiseman JJ, Wiseman SM

    Expert review of anticancer therapy 2021; (21(2)):205-220 doi:10.1080/14737140.2021.1850280.

    PMID: 33176520
  31. 31

    Value of thyroglobulin post hemithyroidectomy for cancer: a literature review.

    Tourani SS, Fleming B, Gundara J

    ANZ journal of surgery 2021; (91(4)):724-729 doi:10.1111/ans.16459.

    PMID: 33244886
  32. 32

    Levothyroxine Therapy in Thyrodectomized Patients.

    Miccoli P, Materazzi G, Rossi L

    Frontiers in endocrinology 2020; (11()):626268 doi:10.3389/fendo.2020.626268.

    PMID: 33584551
  33. 33

    Are molecular tests necessary to diagnose NIFTP?

    Kuchareczko A, Kopczyński J, Kowalik A, et al.

    Genes & cancer 2021; (12()):39-50 doi:10.18632/genesandcancer.213.

    PMID: 33884105
  34. 34

    Thyroid and parathyroid surgeon case volume influences patient outcomes: A systematic review.

    Bedi HK, Jedrzejko N, Nguyen A, et al.

    Surgical oncology 2021; (38()):101550 doi:10.1016/j.suronc.2021.101550.

    PMID: 33915486
  35. 35

    Ultrasound of Thyroid Nodules and the Thyroid Imaging Reporting and Data System.

    Malhi HS, Grant EG

    Neuroimaging clinics of North America 2021; (31(3)):285-300 doi:10.1016/j.nic.2021.04.001.

    PMID: 34243864
  36. 36

    Utility of mutational analysis for risk stratification of indeterminate thyroid nodules in a real-world setting.

    Torrecillas V, Sharma A, Neuberger K, Abraham D

    Clinical endocrinology 2022; (96(4)):637-645 doi:10.1111/cen.14601.

    PMID: 34605038
  37. 37

    Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults.

    Caron P, Grunenwald S, Persani L, et al.

    Reviews in endocrine & metabolic disorders 2022; (23(3)):463-483 doi:10.1007/s11154-021-09691-9.

    PMID: 34671932
  38. 38

    Risk factors for thyroid hormone replacement therapy after hemithyroidectomy and development of a predictive nomogram.

    Cao Z, Liu R, Wu M, et al.

    Endocrine 2022; (76(1)):85-94 doi:10.1007/s12020-021-02971-z.

    PMID: 35067900
  39. 39

    Overview of the 2022 WHO Classification of Thyroid Neoplasms.

    Baloch ZW, Asa SL, Barletta JA, et al.

    Endocrine pathology 2022; (33(1)):27-63 doi:10.1007/s12022-022-09707-3.

    PMID: 35288841
  40. 40

    Follicular Neoplasm of Thyroid Revisited: Current Differential Diagnosis and the Impact of Molecular Testing.

    Ohori NP, Nishino M

    Advances in anatomic pathology 2023; (30(1)):11-23 doi:10.1097/PAP.0000000000000368.

    PMID: 36102526
  41. 41

    How Effective is the Use of Molecular Testing in Preoperative Decision Making for Management of Indeterminate Thyroid Nodules?

    Steinmetz D, Kim M, Choi JH, et al.

    World journal of surgery 2022; (46(12)):3043-3050 doi:10.1007/s00268-022-06744-1.

    PMID: 36167834
  42. 42

    Comparison of Postoperative Unfavorable Events in Patients with Low-Risk Papillary Thyroid Carcinoma: Immediate Surgery Versus Conversion Surgery Following Active Surveillance.

    Sasaki T, Miyauchi A, Fujishima M, et al.

    Thyroid : official journal of the American Thyroid Association 2023; (33(2)):186-191 doi:10.1089/thy.2022.0444.

    PMID: 36205580
  43. 43

    Challenges in Encapsulated Follicular-Patterned Tumors: How Much Is Enough? Evaluation of Nuclear Atypia, Architecture, and Invasion.

    Wong KS, Barletta JA

    Surgical pathology clinics 2023; (16(1)):27-44 doi:10.1016/j.path.2022.09.005.

    PMID: 36739165
  44. 44

    Beware the recurrent 'benign' multinodular goitre.

    Papachristos AJ, Bin Mohamed Ebrahim ME, Fuchs TL, et al.

    ANZ journal of surgery 2023; (93(4)):907-910 doi:10.1111/ans.18355.

    PMID: 36852905
  45. 45

    Active surveillance versus immediate surgery: A comparison of clinical and quality of life outcomes among patients with highly suspicious thyroid nodules 1 cm or smaller in China.

    Liu C, Zhao H, Xia Y, et al.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2023; (49(9)):106917 doi:10.1016/j.ejso.2023.04.016.

    PMID: 37137793
  46. 46

    Posthemithyroidectomy Hypothyroidism: Updated Meta-Analysis of Risk Factors and Rates of Remission.

    Apostolou K, Paunovic I, Frountzas M, et al.

    The Journal of surgical research 2024; (293()):102-120 doi:10.1016/j.jss.2023.08.020.

    PMID: 37734294
  47. 47

    A national study of postoperative thyroid hormone supplementation rates after thyroid lobectomy.

    Hu QL, Chen L, Kuo EJ, et al.

    Surgery 2024; (175(4)):1029-1033 doi:10.1016/j.surg.2023.11.016.

    PMID: 38097483
  48. 48

    Outcomes of Cytologically Indeterminate Thyroid Nodules Managed With Genomic Sequencing Classifier.

    Ahmadi S, Kotwal A, Bikas A, et al.

    The Journal of clinical endocrinology and metabolism 2024; (109(12)):e2231-e2239 doi:10.1210/clinem/dgae112.

    PMID: 38415829
  49. 49

    RAS-Mutant Follicular Thyroid Tumors: A Continuous Challenge for Pathologists.

    Hernandez-Prera JC, Wenig BM

    Endocrine pathology 2024; (35(3)):167-184 doi:10.1007/s12022-024-09812-5.

    PMID: 38888731
  50. 50

    Hypothyroidism after hemithyroidectomy: a systematic review and meta-analysis.

    Cooper D, Kaur R, Ayeni FE, et al.

    Thyroid research 2024; (17(1)):18 doi:10.1186/s13044-024-00200-z.

    PMID: 38972987
  51. 51

    Prognostic factors of papillary and follicular carcinomas based on pre-, intra-, and post-operative findings.

    Ito Y, Miyauchi A

    European thyroid journal 2024; (13(5)).

    PMID: 39213599
  52. 52

    Development of a Nomogram to Integrate Molecular Testing and Clinical Variables to Improve Malignancy Risk Assessment Among Cytologically Indeterminate Thyroid Nodules.

    Wu J, Stewardson P, Eszlinger M, et al.

    Thyroid : official journal of the American Thyroid Association 2025; (35(5)):508-515 doi:10.1089/thy.2024.0481.

    PMID: 40040545
  53. 53

    Cytology-Radiology Correlation Series: Thyroid cytopathology.

    Jug R, Foo WC, Wildman-Tobriner B, Jiang XS

    Cancer cytopathology 2025; (133(8)):e70028 doi:10.1002/cncy.70028.

    PMID: 40699188
  54. 54

    Designing a SPIKES-based protocol for communicating uncertainty in indeterminate thyroid cytology: a mixed-method analysis within a pilot study.

    Melcarne R, Consorti F, Grani G, et al.

    Updates in surgery 2026; (78(1)):75-87 doi:10.1007/s13304-025-02346-3.

    PMID: 40864410
  55. 55

    Risk factors and timing of postoperative hypothyroidism onset following hemithyroidectomy.

    Takata K, Kojima T, Okanoue Y, et al.

    Auris, nasus, larynx 2025; (52(5)):597-604 doi:10.1016/j.anl.2025.08.008.

    PMID: 40912132
  56. 56

    Risks Associated With Extent of Surgical Management for Benign, Non-Toxic Goiter.

    Brady JS, Konuthula N, Lam A, et al.

    Laryngoscope investigative otolaryngology 2025; (10(4)):e70214 doi:10.1002/lio2.70214.

    PMID: 41158116
  57. 57

    Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: an update.

    Van Den Berg NH, Feeley L, Sheahan P

    Current opinion in otolaryngology & head and neck surgery 2026; (34(2)):88-93 doi:10.1097/MOO.0000000000001098.

    PMID: 41213591
  58. 58

    From Lobectomy to Completion Thyroidectomy: A Cohort Study and Systematic Review.

    Tessler I, Yamin T, Caracucli L, et al.

    Clinical endocrinology 2026; (105(1)):108-115 doi:10.1111/cen.70130.

    PMID: 41866695
  59. 59

    Disparities in utilization of high-volume thyroid surgeons for Graves disease: a statewide analysis.

    Xie S, Jensen CB, Sinha A, et al.

    Journal of the Endocrine Society 2026; (10(5)):bvag051 doi:10.1210/jendso/bvag051.

    PMID: 42005303
  60. 60

    Additional detection of Bethesda greater than or equal to III cytology in cold thyroid nodules beyond American College of Radiology Thyroid Imaging Reporting and Data System risk stratification.

    Lavender I, Nandurkar D

    Nuclear medicine communications 2026; (47(9)):1041-1048 doi:10.1097/MNM.0000000000002174.

    PMID: 42144973
  61. 61

    Pathology-based thermal ablation safety margin for follicular adenoma: a digital whole-slide study of follicular carcinoma invasion.

    Qiao Y, Niu Y, Zhao Z, et al.

    Frontiers in endocrinology 2026; (17()):1826810 doi:10.3389/fendo.2026.1826810.

    PMID: 42255449